Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

MLA

Eskander, Ramez N., et al. “Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.” The New England Journal of Medicine, vol. 388, no. 23, June 2023, pp. 2159–70. EBSCOhost, https://doi.org/10.1056/NEJMoa2302312.

APA

Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., Mathews, C., Kavecansky, J., Leath, C. A., 3rd, Gien, L. T., Hinchcliff, E. M., Lele, S. B., Landrum, L. M., Backes, F., O’Cearbhaill, R. E., … Aghajanian, C. (2023). Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer. The New England Journal of Medicine, 388(23), 2159–2170. https://doi.org/10.1056/NEJMoa2302312

Chicago

Eskander, Ramez N, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope, Fernanda B Musa, Robert Mannel, et al. 2023. “Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.” The New England Journal of Medicine 388 (23): 2159–70. doi:10.1056/NEJMoa2302312.